Overexpression of SCARA5 inhibits tumor proliferation and invasion in osteosarcoma via suppression of the FAK signaling pathway

Molecular Medicine Reports

Volumn 13, Issue 3, 2016, Pages 2885-2891

  Wen, Xinzhu ^a   Wang, Nan ^a   Zhang, Fanfan ^a   Dong, Chunjiao ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Focal adhesion kinase signaling pathway; Invasion; Member 5; Osteosarcoma; Scavenger receptor class A

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; SCAVENGER RECEPTOR A; TYROSINE; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, HUMAN; SCARA5 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; MOLECULAR MECHANICS; MTT ASSAY; OSTEOSARCOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING; ADOLESCENT; BONE TUMOR; CASE CONTROL STUDY; CELL MOTION; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; TUMOR CELL LINE; YOUNG ADULT;

ADOLESCENT; ADULT; BONE NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; OSTEOSARCOMA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SCAVENGER RECEPTORS, CLASS A; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84958726043     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.4857     Document Type: Article

References (29)

1. Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer 115: 1531-1543, 2009.
2. Amankwah EK, Conley AP and Reed DR: Epidemiology and therapies for metastatic sarcoma. Clin Epidemiol 5: 147-162, 2013.
3. Friedman MA and Carter SK: The therapy of osteogenic sarcoma: Current status and thoughts for the future. J Surg Oncol 4: 482-510, 1972.
4. Peiser L and Gordon S: The function of scavenger receptorsexpressed by macrophages and their role in the regulation of inflammation. Microbes Infect 3: 149-159, 2001.
5. Platt N, Haworth R, Darley L and Gordon S: The many roles of the class A macrophage scavenger receptor. Int Rev Cytol 212: 1-40, 2002.
6. Elomaa O, Sankala M, Pikkarainen T, Bergmann U, Tuuttila A, Raatikainen-Ahokas A, Sariola H and Tryggvason K: Structure of the human macrophage MARCO receptor and characterization of its bacteria-binding region. J Biol Chem 273: 4530-4538, 1998.
7. Han HJ, Tokino T and Nakamura Y: CSR, a scavenger receptor-like protein with a protective role against cellular damage caused by UV irradiation and oxidative stress. Hum Mol Genet 7: 1039-1046, 1998.
8. Ohtani K, Suzuki Y, Eda S, Kawai T, Kase T, Keshi H, Sakai Y, Fukuoh A, Sakamoto T, Itabe H, et al: The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J Biol Chem 276: 44222-44228, 2001.
9. Jiang Y, Oliver P, Davies KE and Platt N: Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. J Biol Chem 281: 11834-11845, 2006.
10. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, et al: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296, 1997.
11. Liu J, Hu G, Chen D, Gong AY, Soori GS, Dobleman TJ and Chen XM: Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis 2: e73, 2013.
12. Huang J, Zheng DL, Qin FS, Cheng N, Chen H, Wan BB, Wang YP, Xiao HS and Han ZG: Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J Clin Invest 120: 223-241, 2010.
13. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 25: 402-408, 2001.
14. Kruger NJ: The Bradford method for protein quantitation. Methods Mol Biol 32: 9-15, 1994.
15. Sulzmaier FJ, Jean C and Schlaepfer DD: FAK in cancer: Mechanistic findings and clinical applications. Nat Rev Cancer 14: 598-610, 2014.
16. Fingleton B: Matrix metalloproteinases: Roles in cancer and metastasis. Front Biosci 11: 479-491, 2006.
17. Yu G, Tseng GC, Yu YP, Gavel T, Nelson J, Wells A, Michalopoulos G, Kokkinakis D and Luo JH: CSR1 suppresses tumor growth and metastasis of prostate cancer. Am J Pathol 168: 597-607, 2006.
18. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66: 10439-10448, 2006.
19. Bock AJ, Nymoen DA, Brenne K, Kårn J and Davidson B: SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Hum Pathol 43: 669-674, 2012.
20. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2: 249-256, 2000.
21. Tilghman RW and Parsons JT: Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18: 45-52, 2008.
22. Schlaepfer DD, Mitra SK and Ilic D: Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692: 77-102, 2004.
23. Seong BK, Lau J, Adderley T, Kee L, Chaukos D, Pienkowska M, Malkin D, Thorner P and Irwin MS: SATB2 enhances migration and invasion in osteosarcoma by regulating genes involved in cytoskeletal organization. Oncogene 34: 3582-3592, 2015.
24. Hu Y, Xu S, Jin W, Yi Q and Wei W: Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells. Oncol Rep 32: 1741-1747, 2014.
25. Park GB, Kim DJ, Kim YS, Lee HK, Kim CW and Hur DY: Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents. Int J Oncol 46: 185-194, 2015.
26. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997.
27. Kido A, Tsutsumi M, Iki K, Takahama M, Tsujiuchi T, Morishita T, Tamai S and Konishi Y: Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats. Cancer lett 137: 209-216, 1999.
28. Himelstein BP, Asada N, Carlton MR and Collins MH: Matrix metalloproteinaseå9 (MMPå9) expression in childhood osseous osteosarcoma. Med Pediatr Oncol 31: 471-474, 1998.
29. Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K and Ishiguro N: Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol 28: 33-42, 2006.